Levetiracetam Tablets — Class II drug recall D-1702-2012
Terminated recall by Mylan Pharmaceuticals Inc., reported 2012-10-03, distributed in KY. Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in b
| Recall number | D-1702-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Pharmaceuticals Inc., Morgantown, WV, United States |
| Recall initiated | 2012-07-27 |
| Classified | 2012-09-27 |
| Reported by FDA | 2012-10-03 |
| Terminated | 2013-05-21 |
| Distributed | KY |
| Quantity | 960 bottles |
| NDC | 00378-5615, 00378-5615-05, 00378-5615-78, 00378-5617, 00378-5617-05, 00378-5617-78, 00378-5619, 00378-5619-91 |
| Lot numbers | ZLMM12063 |
| Expiration dates | 2014-03-20 |
Product
Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05
Reason for recall
Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1702-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.